Daewoong Pharmaceutical Co (XKRX:069620) Long-Term Debt : ₩324,478 Mil (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Daewoong Pharmaceutical Co Long-Term Debt?

Daewoong Pharmaceutical Co's Long-Term Debt for the quarter that ended in Dec. 2024 was ₩324,478 Mil.

Daewoong Pharmaceutical Co's quarterly Long-Term Debt increased from Jun. 2024 (₩259,255 Mil) to Sep. 2024 (₩337,340 Mil) but then declined from Sep. 2024 (₩337,340 Mil) to Dec. 2024 (₩324,478 Mil).

Daewoong Pharmaceutical Co's annual Long-Term Debt declined from Dec. 2022 (₩204,840 Mil) to Dec. 2023 (₩65,000 Mil) but then increased from Dec. 2023 (₩65,000 Mil) to Dec. 2024 (₩324,478 Mil).

Daewoong Pharmaceutical Co Long-Term Debt Historical Data

The historical data trend for Daewoong Pharmaceutical Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daewoong Pharmaceutical Co Long-Term Debt Chart

Daewoong Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

291,165.32

181,712.79

204,840.00

65,000.00

324,477.60

Daewoong Pharmaceutical Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															65,000.00	65,000.00	259,254.97	337,340.05	324,477.60

Daewoong Pharmaceutical Co (XKRX:069620) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Daewoong Pharmaceutical Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Daewoong Pharmaceutical Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Daewoong Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daewoong Pharmaceutical Co Ltd (XKRX:069620) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

12, Bongeunsa-ro 114-gil, Daewoong Pharmaceutical Building, Gangnam-gu, Seoul, KOR

Website

https://www.daewoong.co.kr

Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.

Daewoong Pharmaceutical Co Headlines

No Headlines